ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Mannkind Corporation · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
mac lung disease, treatment refractory mac lung disease, mycobacterium infections, nontuberculous, bronchiectasis, ntm (nontuberculous mycobacteria), mac (mycobacterium avium complex), mabsc (mycobacterium abscessus complex), pulmonary nontuberculous mycobacteria, respiratory infection, antimycobacterial activity, antimycobacterial therapy, mac infections
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 806514
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.